Literature DB >> 10233328

The association of latent Epstein-Barr virus infection with hydroa vacciniforme.

K Iwatsuki1, Z Xu, M Takata, M Iguchi, M Ohtsuka, H Akiba, Y Mitsuhashi, H Takenoshita, R Sugiuchi, H Tagami, F Kaneko.   

Abstract

Patients with hydroa vacciniforme (HV)-like eruptions and malignant potential have been reported from Asia and Mexico, and those patients frequently had an associated latent Epstein-Barr virus (EBV) infection. In order to elucidate the association of latent EBV infection with HV, we studied six children with typical manifestations of HV by detection of EBV genes and EBV-related RNAs in biopsy specimens from cutaneous lesions. Cutaneous lesions of all six children with typical HV contained EBV-encoded small nuclear RNA (EBER)+ cells in 3-10% of the dermal infiltrates, whereas no Bam HI-H, l-fragment (BHLF) mRNA, or transcripts encoding EA-D antigen, were detected. No EBER + cells were detected in other inflammatory or benign lymphoproliferative skin disorders tested. Polymerase chain reaction amplification confirmed the presence of EBV DNA sequences in five of six biopsy specimens from the patients. Latent EBV infection is associated with the development of cutaneous lesions of HV.

Entities:  

Mesh:

Year:  1999        PMID: 10233328     DOI: 10.1046/j.1365-2133.1999.02777.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  22 in total

1.  Anterior keratouveitis secondary to Hydroa vaccineforme: a role for ophthalmic slit-lamp examination in this condition?

Authors:  S Trikha; A Turnbull; N Srikantha; R Krishnan; A Tappin
Journal:  BMJ Case Rep       Date:  2011-04-13

2.  Ocular findings as a presenting sign of hydroa vacciniforme.

Authors:  B H Jeng; T P Margolis; N S Chandra; T H McCalmont
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

3.  [Umbilicated blisters on sun-exposed skin].

Authors:  E Stancu; M Braun-Falco; L Bruckner-Tuderman; C M Schempp
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

4.  Hidroa vacciniforme.

Authors:  Aslı Feride Kaptanoğlu; Özlem Şahaloğlu; Cem Çomunoğlu
Journal:  Turk Pediatri Ars       Date:  2014-06-01

5.  Defining the elusive boundaries of chronic active Epstein-Barr virus infection.

Authors:  Sebastian Fernandez-Pol; Oscar Silva; Yasodha Natkunam
Journal:  Haematologica       Date:  2018-06       Impact factor: 9.941

6.  A Case of Epstein-Barr Virus-associated Hydroa Vacciniforme.

Authors:  Sun Young Huh; Mira Choi; Kwang Hyun Cho
Journal:  Ann Dermatol       Date:  2009-05-31       Impact factor: 1.444

Review 7.  The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.

Authors:  Rein Willemze; Lorenzo Cerroni; Werner Kempf; Emilio Berti; Fabio Facchetti; Steven H Swerdlow; Elaine S Jaffe
Journal:  Blood       Date:  2019-01-11       Impact factor: 22.113

8.  Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.

Authors:  Anja Pahlow Mose; Niels Fisker; Ole Clemmensen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2014-11-24

9.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

10.  Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions.

Authors:  Taizo Wada; Akiko Toga; Yasuhisa Sakakibara; Tomoko Toma; Minoru Hasegawa; Kazuhiko Takehara; Tomonari Shigemura; Kazunaga Agematsu; Akihiro Yachie
Journal:  Int J Hematol       Date:  2012-08-12       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.